Torno Capital’s Novartis NVS Stock Holding History

Torno Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-50,000	Closed	-$5.32M	–	278
2024 Q2	$5.32M	Buy	+50,000	New	+$5.02M	0.25%	38

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Torno Capital's NVS Position: Q3 2024 in Review

Torno Capital sold out of Novartis (NVS) in Q3 2024, closing a stake of 7,500 shares — an estimated $798K sold.

Torno Capital first reported a position in NVS in Q2 2024 and held it in 1 quarter. The position peaked at $798K in Q2 2024. 1,312 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

Torno Capital reported no remaining Novartis position as of Q3 2024 after selling out during the quarter.
Torno Capital sold 7,500 Novartis shares in Q3 2024, an estimated $798K.
Torno Capital first reported a position in Novartis in Q2 2024 and held it in 1 quarter.
Torno Capital's Novartis position peaked at $798K in Q2 2024.
1,312 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on Torno Capital's 13F filing for Q3 2024, filed 13 Nov 2024.